These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28521022)

  • 41. Bupivacaine Toxicity Increases Transmural Dispersion of Repolarization, Developing of a Brugada-like Pattern and Ventricular Arrhythmias, Which is Reversed by Lipid Emulsion Administration. Study in an Experimental Porcine Model.
    De Diego C; Zaballos M; Quintela O; Sevilla R; Callejo D; González-Panizo J; Anadón MJ; Almendral J
    Cardiovasc Toxicol; 2019 Oct; 19(5):432-440. PubMed ID: 30945064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SCN5A mutation type and topology are associated with the risk of ventricular arrhythmia by sodium channel blockers.
    Amin AS; Reckman YJ; Arbelo E; Spanjaart AM; Postema PG; Tadros R; Tanck MW; Van den Berg MP; Wilde AAM; Tan HL
    Int J Cardiol; 2018 Sep; 266():128-132. PubMed ID: 29709244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-Peak to T-End Interval for Prediction of Positive Response to Ajmaline Challenge Test in Suspected Brugada Syndrome Patients.
    Thapanasuta M; Chokesuwattanaskul R; Leelapatana P; Rungpradubvong V; Prechawat S
    Med Sci (Basel); 2022 Dec; 10(4):. PubMed ID: 36548004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brugada Syndrome Presenting as Polymorphic Ventricular Tachycardia-Ventricular Fibrillation Lasting 94 Seconds Recorded on an Ambulatory Monitor.
    Russo CR; Welch TD; Sangha RS; Greenberg ML
    JAMA Intern Med; 2015 Dec; 175(12):1951-4. PubMed ID: 26501938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Malignant Purkinje ectopy induced by sodium channel blockers.
    Escande W; Gourraud JB; Haissaguerre M; Gandjbakhch E; Lavergne T; Martins R; Cheniti G; Krisai P; Hermida JS; Maury P; Merino JL; Pasquié JL; Combes N; Surget E; Duchateau J; Pambrun T; Derval N; Hocini M; Jaïs P; Postema PG; Nademanee K; Vigmond E; Bernus O; Sacher F; Probst V
    Heart Rhythm; 2022 Oct; 19(10):1595-1603. PubMed ID: 35835363
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Augmented QRS notching and macroscopic T-wave alternans preceding polymorphic ventricular tachycardia in a patient with electrical storm.
    Minatoguchi S; Takasugi N; Kubota T; Ushikoshi H; Nishigaki K; Minatoguchi S
    Europace; 2017 Apr; 19(4):643. PubMed ID: 28339622
    [No Abstract]   [Full Text] [Related]  

  • 49. Abnormal restitution property of action potential duration and conduction delay in Brugada syndrome: both repolarization and depolarization abnormalities.
    Nishii N; Nagase S; Morita H; Kusano KF; Namba T; Miura D; Miyaji K; Hiramatsu S; Tada T; Murakami M; Watanabe A; Banba K; Sakai Y; Nakamura K; Oka T; Ohe T
    Europace; 2010 Apr; 12(4):544-52. PubMed ID: 20083482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Lambiase PD
    Europace; 2010 Feb; 12(2):158-9. PubMed ID: 20045864
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ventricular arrhythmias and sudden cardiac death.
    John RM; Tedrow UB; Koplan BA; Albert CM; Epstein LM; Sweeney MO; Miller AL; Michaud GF; Stevenson WG
    Lancet; 2012 Oct; 380(9852):1520-9. PubMed ID: 23101719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical Presentation and Outcome of Brugada Syndrome Diagnosed With the New 2013 Criteria.
    Curcio A; Mazzanti A; Bloise R; Monteforte N; Indolfi C; Priori SG; Napolitano C
    J Cardiovasc Electrophysiol; 2016 Aug; 27(8):937-43. PubMed ID: 27098113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator.
    Kim SH; Nam GB; Baek S; Choi HO; Kim KH; Choi KJ; Joung B; Pak HN; Lee MH; Kim SS; Park SJ; On YK; Kim JS; Oh IY; Choi EK; Oh S; Choi YS; Choi JI; Park SW; Kim YH; Lee MY; Lim HE; Lee YS; Cho Y; Kim J; Lee DI; Cho DK; Kim YH
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):757-63. PubMed ID: 22353358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence and initial characteristics of pilsicainide-induced ventricular arrhythmias in patients with Brugada syndrome.
    Chinushi M; Komura S; Izumi D; Furushima H; Tanabe Y; Washizuka T; Aizawa Y
    Pacing Clin Electrophysiol; 2007 May; 30(5):662-71. PubMed ID: 17461877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias.
    Junttila MJ; Gonzalez M; Lizotte E; Benito B; Vernooy K; Sarkozy A; Huikuri HV; Brugada P; Brugada J; Brugada R
    Circulation; 2008 Apr; 117(14):1890-3. PubMed ID: 18391123
    [No Abstract]   [Full Text] [Related]  

  • 57. Conversion of Brugada type I to type III and successful control of recurrent ventricular arrhythmia with cilostazol.
    Ağaç MT; Erkan H; Korkmaz L
    Arch Cardiovasc Dis; 2014; 107(8-9):476-8. PubMed ID: 23791603
    [No Abstract]   [Full Text] [Related]  

  • 58. A reliable witness: dual-chamber pacemaker prolonged intracardiac recordings of a resuscitated cardiac arrest episode.
    De Mattia L; Brieda M; Dametto E; Del Bianco F; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 1():S5-7. PubMed ID: 23448965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Baseline fragmented QRS increases the risk of major arrhythmic events in Brugada syndrome: Systematic review and meta-analysis.
    Rattanawong P; Riangwiwat T; Prasitlumkum N; Limpruttidham N; Kanjanahattakij N; Chongsathidkiet P; Vutthikraivit W; Chung EH
    Ann Noninvasive Electrocardiol; 2018 Mar; 23(2):e12507. PubMed ID: 29030919
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Very prolonged episode of self-terminating ventricular fibrillation in a patient with Brugada syndrome.
    Boulé S; Kouakam C; Brigadeau F
    Can J Cardiol; 2013 Dec; 29(12):1742.e1-3. PubMed ID: 24267814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.